Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06386003 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jan 2027 → Jan 2028
See other at-risk trials from Unity Health Toronto

Record History

  1. Primary completion pushed from Jan 2027 to Jan 2028 Enrollment closed, study ongoing · Completion pushed from Jan 2027 to Jun 2028 · Start date changed from estimate of Jun 2026 to Jun 1, 2026 · 4 more Show 7 more changesShow less
    • Enrollment closed, study ongoing
    • Completion pushed from Jan 2027 to Jun 2028
    • Start date changed from estimate of Jun 2026 to Jun 1, 2026
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 4 of 20 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Recruitment opened Start date: May 2026 to Jun 2026 · Site details revisedv4 Show 2 more changesShow less
    • Start date: May 2026 to Jun 2026
    • Site details revised
  3. Start date: Mar 2026 to May 2026v3
  4. Primary completion date: Mar 2025 to Jan 2027 Start date: Aug 2024 to Mar 2026 · Completion date: May 2025 to Jan 2027 · Secondary endpoints: 19 to 20v2 Show 3 more changesShow less
    • Start date: Aug 2024 to Mar 2026
    • Completion date: May 2025 to Jan 2027
    • Secondary endpoints: 19 to 20

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Unity Health Toronto
85 trials monitored
See 4 trials at risk
PTSD
821 trials monitored
See 49 trials at risk
This is an open-label trial evaluating feasibility, tolerability, safety and efficacy of psilocybin assisted cognitive processing therapy for chronic Posttraumatic Stress Disorder (PTSD).
Trial Details
NCT Number NCT06386003
Lead Sponsor Unity Health Toronto
Collaborators: Toronto Metropolitan University, University of Ottawa
Conditions Post Traumatic Stress Disorder, PTSD, Chronic PTSD
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov